Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Current Drug Discovery Technologies|March 14, 2026
Potential of Using Cannabidiol as a Therapeutic Molecule Against Various Cell Signaling Molecules Involved in Breast Cancer Complications: A Bioinformatics ApproachSandip Mondal, Manish Kumar Gautam, Aminul Islam, et al.
Current Medical Research and Opinion|December 11, 2020
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responsesTapan Kumar Mukherjee, Parth Malik, Radhashree Maitra, et al.
Molecular Biology Reports|August 20, 2018
Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albuminMeenu Narwal, Deepak Kumar, Tapan Kumar Mukherjee, et al.
Current Pharmaceutical Design|January 4, 2024
Recent Progress in the Hesperetin Delivery Regimes: Significance of Pleiotropic Actions and Synergistic Anticancer EfficacyParth Malik, Manju Bernela, Mahima Seth, et al.
Journal of Nanobiotechnology|April 6, 2016
Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malariaShadab Alam, Jiban Jyoti Panda, Tapan Kumar Mukherjee, et al.
Current Topics in Medicinal Chemistry|January 4, 2023
Understanding the Phytoestrogen Genistein Actions on Breast Cancer: Insights on Estrogen Receptor Equivalence, Pleiotropic Essence and Emerging Paradigms in Bioavailability ModulationParth Malik, Raj Singh, Mukesh Kumar, et al.
Avicenna Journal of Phytomedicine|April 21, 2026
Nordihydroguaiaretic acid attenuates TNFα-dependent intercellular adhesion molecule-1 expression in cultured human umbilical vein endothelial cells via targeting TNFα-PI3K-NF-κB-ICAM1 pathwayTapan Kumar Mukherjee, Parth Malik, Raj Singh, et al.
Current Pharmaceutical Design|June 12, 2026
Receptor for Advanced Glycation End Products (RAGE) Ligand Axis as a Mediator of Inflammation and Oxidative Stress in Cancer: Implications for Cancer Progression and Therapeutic TargetingSandip Mondal, Payel Chakraborty, Souvik Ghatak, et al.
Exploration of Targeted Anti-Tumor Therapy|November 16, 2023
Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapiesParth Malik, Ruma Rani, Raghu Solanki, et al.
Pharmacological Reports : PR|June 24, 2023
Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatmentsRaj Singh, Parth Malik, Mukesh Kumar, et al.
Pageof 3